Disclosures for "Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6-48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine ")
-
Dr. Sunzel has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Sunzel has stock in Teva Pharmaceuticals. An immediate family member of Dr. Sunzel has stock in Incyte.
-
Dr. Ghibellini has received personal compensation for serving as an employee of Teva Pharmaceutical. Dr. Ghibellini has stock in Teva Pharmaceuticals.
-
Ms. Iyengar has received personal compensation for serving as an employee of Teva. Ms. Iyengar has stock in Teva.
-
Dr. Gutierrez has stock in Teva.
-
Mrs. Ruffo has nothing to disclose.
-
Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
-
Laura Rabinovich-Guilatt has received personal compensation for serving as an employee of Teva Pharmaceuticals. Laura Rabinovich-Guilatt has stock in Teva Pharmaceuticals.